Latest news
Guggenheim Reiterates Neutral Rating for Sionna Therapeutics (NASDAQ:SION) - MarketBeatMarketBeat · Mon, 10 Aug 2026 18:14:23 GMTUltragenyx Pharmaceutical's (RARE) Buy Rating Reiterated at HC Wainwright - MarketBeatMarketBeat · Mon, 10 Aug 2026 12:23:46 GMTSpotify Technology (NYSE:SPOT) Earns Buy Rating from Guggenheim - MarketBeatMarketBeat · Wed, 05 Aug 2026 13:12:40 GMTStoke Therapeutics (NASDAQ:STOK) Earns Buy Rating from Guggenheim - MarketBeatMarketBeat · Tue, 04 Aug 2026 14:28:54 GMTNIKE's (NKE) Underweight Rating Reiterated at JPMorgan Chase & Co. - MarketBeatMarketBeat · Tue, 04 Aug 2026 12:18:55 GMTSirius XM's (SIRI) Buy Rating Reiterated at Rosenblatt Securities - MarketBeatMarketBeat · Tue, 28 Jul 2026 12:40:00 GMT